Effectiveness of Integrated Network for Student Psychosocial Intervention, Resilience, and Education (INSPIRE) on Mental Health Outcomes Among Indonesian Adolescents in Bandung
Launched by NATIONAL UNIVERSITY OF SINGAPORE · Apr 17, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The INSPIRE trial is a school-based program aimed at improving mental health among adolescents in Bandung, Indonesia. Over eight weeks, school counselors will work with students aged 13 to 15 to help them learn about mental health, build resilience, and address feelings of depression and anxiety. The program includes engaging lessons and activities, and parents will also receive resources to support their children. The study will compare the experiences of students participating in this program to those receiving standard care, to see if INSPIRE helps improve mental health knowledge and reduce symptoms of anxiety and depression.
To join the trial, adolescents must be healthy, unmarried, and enrolled in a public junior high school, while parents or guardians need to communicate in Bahasa Indonesia. Participants can expect to learn valuable information about mental health and gain skills to cope with challenges. This research is important as it seeks to understand how effective the INSPIRE program is in promoting better mental health outcomes for both students and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- The inclusion criteria for adolescents are as follows:
- • Unmarried, 13-15 years old, school-going, healthy adolescents enrolled in an Indonesian public junior high school
- • Able to read, understand, and converse in Bahasa Indonesia.
- The inclusion criteria for parents are as follows:
- • The biological father, mother, or an adult who fulfils a parental or guardian role for the participating adolescent
- • Able to understand and communicate in Bahasa Indonesia.
- Exclusion Criteria:
- • Adolescents who are working, clinically diagnosed with severe mental disorders, such as schizophrenia or psychosis, at high risk for mental health disorders (e.g., teenage pregnancy), or are cognitively impaired will be excluded.
- • Parents with severe mental disorders or cognitive impairment that may hinder participation will be excluded.
About National University Of Singapore
The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported